DeepMed Research

Seoul National University Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 2003-01-01

Employees: 501

Market Cap: -

Website: https://www.snubh.org

Clinical Trials

Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)

Phase 4

Conditions: Coronary Artery Disease

Interventions: Device: XIENCE PRIMETM everolimus-eluting coronary stent

First Posted Date: 2012-05-25

Last Posted Date: 2012-05-25

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 2000

Registration Number: NCT01605721

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome

Phase 3

Completed

Conditions: Dry Eye
Sjogren's Syndrome
Autoimmune Diseases

Interventions: Drug: Hydroxychloroquine
Drug: Placebo

First Posted Date: 2012-05-17

Last Posted Date: 2013-10-17

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 39

Registration Number: NCT01601028

Locations: 🇰🇷
Seoul National Unversity Hospital, Seoul, Korea, Republic of

A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF]

Phase 3

Conditions: Diastolic Heart Failure

Interventions: Drug: Placebo
Drug: Udenafil (Zydena)

First Posted Date: 2012-05-15

Last Posted Date: 2013-01-31

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 52

Registration Number: NCT01599117

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment

Not Applicable

Completed

Conditions: End Stage Renal Disease

Interventions: Procedure: Duplex ultrasonography

First Posted Date: 2012-05-11

Last Posted Date: 2015-05-27

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 150

Registration Number: NCT01597115

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Foley Catheter Versus Dinoprostone Vaginal Insert for Induction of Labor in Parous Women at Term: A Randomized Trial

Not Applicable

Completed

Conditions: Failed Induction of Labor

Interventions: Drug: Dinoprostone 10mg
Device: Transcervical foley catheter

First Posted Date: 2012-05-10

Last Posted Date: 2020-03-03

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 154

Registration Number: NCT01596296

Locations: 🇰🇷
Department of Obstetrics and Gynecology Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

Lexapro®'s Efficacy After Dose Escalation in Remission Study

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: escitalopram

First Posted Date: 2012-05-09

Last Posted Date: 2018-09-07

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 60

Registration Number: NCT01594866

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

Phase 2

Completed

Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast

Interventions: Drug: Metformin
Drug: Placebo

First Posted Date: 2012-05-01

Last Posted Date: 2018-09-10

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 208

Registration Number: NCT01589367

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)

Phase 4

Conditions: Critical Stenosis of Aortic Valve

Interventions: Drug: Placebo
Drug: Fimasartan

First Posted Date: 2012-05-01

Last Posted Date: 2012-05-02

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 100

Registration Number: NCT01589380

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of

and more 4 locations

Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: clopidogrel napadisilate + aspirin
Drug: clopidogrel bisulfate + aspirin

First Posted Date: 2012-04-25

Last Posted Date: 2012-04-25

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 148

Registration Number: NCT01584791

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients

Phase 2

Conditions: Symptomatic Bronchiectasis

Interventions: Drug: Roflumilast

First Posted Date: 2012-04-19

Last Posted Date: 2012-04-19

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 25

Registration Number: NCT01580748

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeongi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy